TY - JOUR
T1 - Effectiveness of an intensive, functional, gamified Rehabilitation program in improving upper limb motor function in people with stroke
T2 - A protocol of the EnteRtain randomized clinical trial
AU - Sulfikar Ali, A.
AU - Arumugam, Ashokan
AU - Kumaran D, Senthil
N1 - Funding Information:
This study is partially funded by an industry grant provided through the BeAble Health Pvt Ltd. (IIT Hyderabad, Telangana, India), a company that manufactures and markets the ArmAble™ device. However, the funders do not have any role in the conception, design, execution, data analysis and interpretation, and dissemination of the findings of this study.
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/6
Y1 - 2021/6
N2 - Introduction: Game-based rehabilitation is an emerging therapeutic intervention that allows intensive, repetitive, task-based training to improve upper limb (UL) function following stroke, based on the principles of neuro-plasticity and motor (re)learning. Rehabilitation using commercial gaming system will be motivating, enjoyable, challenging and affordable. Therefore, the present study aims at assessing the effectiveness of an intensive, functional, gamified rehabilitation program using the ArmAble™ device in improving UL motor function in people with stroke. Method: In this single-blinded, multi-centric, randomized clinical trial, 120 adults with acute/sub-acute unilateral stroke will be randomized to receive an intensive, functional, gamified training program using the ArmAble™ or task-based training along with a conventional therapy for 2 h/day, 6 days/week for 2 weeks, followed by a home-based, functional rehabilitation program for another 4 weeks (~30 min/day, 6 days/week). Primary outcomes evaluated by a blinded assessor at the baseline, 2 weeks and 6 weeks' post-intervention will include the Fugl-Meyer assessment – upper extremity and the action research arm test. A linear mixed effect regression model or relevant non-parametric tests will be used to analyze the data for all outcomes. An intention-to-treat analysis will be used with missing data handled by multiple imputation. Discussion: Rehabilitation provided with the ArmAble™ device, if found effective, can be used from the early stages post-stroke to provide intensive, repetitive, gamified training to improve UL motor function. Trial registration number: CTRI/2020/09/027651.
AB - Introduction: Game-based rehabilitation is an emerging therapeutic intervention that allows intensive, repetitive, task-based training to improve upper limb (UL) function following stroke, based on the principles of neuro-plasticity and motor (re)learning. Rehabilitation using commercial gaming system will be motivating, enjoyable, challenging and affordable. Therefore, the present study aims at assessing the effectiveness of an intensive, functional, gamified rehabilitation program using the ArmAble™ device in improving UL motor function in people with stroke. Method: In this single-blinded, multi-centric, randomized clinical trial, 120 adults with acute/sub-acute unilateral stroke will be randomized to receive an intensive, functional, gamified training program using the ArmAble™ or task-based training along with a conventional therapy for 2 h/day, 6 days/week for 2 weeks, followed by a home-based, functional rehabilitation program for another 4 weeks (~30 min/day, 6 days/week). Primary outcomes evaluated by a blinded assessor at the baseline, 2 weeks and 6 weeks' post-intervention will include the Fugl-Meyer assessment – upper extremity and the action research arm test. A linear mixed effect regression model or relevant non-parametric tests will be used to analyze the data for all outcomes. An intention-to-treat analysis will be used with missing data handled by multiple imputation. Discussion: Rehabilitation provided with the ArmAble™ device, if found effective, can be used from the early stages post-stroke to provide intensive, repetitive, gamified training to improve UL motor function. Trial registration number: CTRI/2020/09/027651.
UR - http://www.scopus.com/inward/record.url?scp=85105834558&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105834558&partnerID=8YFLogxK
U2 - 10.1016/j.cct.2021.106381
DO - 10.1016/j.cct.2021.106381
M3 - Article
C2 - 33862286
AN - SCOPUS:85105834558
SN - 1551-7144
VL - 105
JO - Contemporary Clinical Trials
JF - Contemporary Clinical Trials
M1 - 106381
ER -